(Q50796431)

English

Reirradiation for recurrent malignant brain tumor with radiotherapy or proton beam therapy. Technical considerations based on experience at a single institution.

scientific article published on 5 July 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23824106

Reirradiation for recurrent malignant brain tumor with radiotherapy or proton beam therapy. Technical considerations based on experience at a single institution. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23824106

adaptive radiation therapy

0 references

1 reference

based on heuristic

inferred from title

Masashi Mizumoto

1

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23824106

author name string

T Okumura

2

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23824106

E Ishikawa

3

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23824106

T Yamamoto

4

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23824106

S Takano

5

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23824106

A Matsumura

6

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23824106

Y Oshiro

7

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23824106

H Ishikawa

8

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23824106

H Sakurai

9

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23824106

K Tsuboi

10

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23824106

publication date

5 July 2013

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23824106

Strahlentherapie und Onkologie

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23824106

189

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23824106

8

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23824106

656-663

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23824106

Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0390-6

21 January 2018

Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM).

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0390-6

21 January 2018

Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0390-6

21 January 2018

Hypofractionated stereotactic reirradiation of recurrent glioblastomas : a beneficial treatment option after high-dose radiotherapy?

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0390-6

21 January 2018

Efficacy of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0390-6

21 January 2018

Fractionated stereotactic reirradiation and concurrent temozolomide in patients with recurrent glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0390-6

21 January 2018

Reirradiation tolerance of the human brain

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0390-6

21 January 2018

Outcome of T4 (International Union Against Cancer Staging System, 7th edition) or recurrent nasal cavity and paranasal sinus carcinoma treated with proton beam.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0390-6

21 January 2018

Clinical results of proton beam therapy for skull base chordoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0390-6

21 January 2018

Phase I/II trial of hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0390-6

21 January 2018

Proton beam therapy for hepatocellular carcinoma: a comparison of three treatment protocols

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0390-6

21 January 2018

Relative biological effectiveness of proton beams in clinical therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0390-6

21 January 2018

Relative biological effectiveness (RBE) values for proton beam therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0390-6

21 January 2018

Adjuvant intensity-modulated proton therapy in malignant pleural mesothelioma. A comparison with intensity-modulated radiotherapy and a spot size variation assessment

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0390-6

21 January 2018

Clinical results of proton-beam therapy for locoregionally advanced esophageal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23824106

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stereotactic body radiation therapy (SBRT) for treatment of adrenal gland metastases from non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23824106

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of proton beam therapy without concurrent chemotherapy for patients with unresectable stage III non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23824106

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose fractionation, dose rate and iso-effect relationships for normal tissue responses.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23824106

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00066-013-0390-6

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23824106

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23824106

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50796431&oldid=2210517301"